EyePoint Pharmaceuticals Inc (EYPT)
10.40
-0.08
(-0.81%)
USD |
NASDAQ |
Nov 15, 09:55
EyePoint Pharmaceuticals Cash and Short Term Investments (Quarterly): 253.79M for Sept. 30, 2024
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 253.79M |
| June 30, 2024 | 280.25M |
| March 31, 2024 | 299.35M |
| December 31, 2023 | 331.05M |
| September 30, 2023 | 136.01M |
| June 30, 2023 | 142.54M |
| March 31, 2023 | 122.48M |
| December 31, 2022 | 144.56M |
| September 30, 2022 | 157.26M |
| June 30, 2022 | 171.17M |
| March 31, 2022 | 190.78M |
| December 31, 2021 | 211.56M |
| September 30, 2021 | 119.71M |
| June 30, 2021 | 127.63M |
| March 31, 2021 | 138.58M |
| December 31, 2020 | 44.91M |
| September 30, 2020 | 28.73M |
| June 30, 2020 | 22.81M |
| March 31, 2020 | 26.30M |
| December 31, 2019 | 22.21M |
| September 30, 2019 | 31.76M |
| June 30, 2019 | 44.16M |
| March 31, 2019 | 43.38M |
| September 30, 2018 | 55.76M |
| June 30, 2018 | 38.78M |
| Date | Value |
|---|---|
| March 31, 2018 | 16.35M |
| December 31, 2017 | 12.88M |
| September 30, 2017 | 11.83M |
| June 30, 2017 | 16.90M |
| March 31, 2017 | 15.37M |
| December 31, 2016 | 17.53M |
| September 30, 2016 | 22.55M |
| June 30, 2016 | 28.99M |
| March 31, 2016 | 33.27M |
| December 31, 2015 | 21.09M |
| September 30, 2015 | 24.00M |
| June 30, 2015 | 28.54M |
| March 31, 2015 | 31.66M |
| December 31, 2014 | 35.69M |
| September 30, 2014 | 14.31M |
| June 30, 2014 | 18.28M |
| March 31, 2014 | 21.27M |
| December 31, 2013 | 15.72M |
| September 30, 2013 | 16.45M |
| June 30, 2013 | 10.27M |
| March 31, 2013 | 13.70M |
| December 31, 2012 | 15.72M |
| September 30, 2012 | 17.65M |
| June 30, 2012 | 14.57M |
| March 31, 2012 | 16.46M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
22.21M
Minimum
Dec 2019
331.05M
Maximum
Dec 2023
148.58M
Average
140.56M
Median
Cash and Short Term Investments (Quarterly) Benchmarks
| Cassava Sciences Inc | 148.98M |
| Regeneron Pharmaceuticals Inc | 9.796B |
| Adverum Biotechnologies Inc | 153.24M |
| Regenxbio Inc | 255.46M |
| Editas Medicine Inc | 265.09M |